Haystack MRD™ Monitoring
Test code
CPT code(s)*
Clinical significance
Test resources
Test FAQ
Test summary
Details
Methodology
Next Generation Sequencing
Assay category
This test was developed and its analytical performance characteristics have been determined by Quest Diagnostics. It has not been cleared or approved by FDA. This assay has been validated pursuant to the CLIA regulations and is used for clinical purposes.
Alternative name(s)
MRD Clearance,Minimal Residual Disease,Mutation Tracking,Precision Oncology,Relapse Prediction,Tumor Burden Profiling,Tumor-Specific Mutations,NGS,Cancer Therapy,Cancer Discovery,Cancer Genomics,Circulating DNA,Circulating Tumor DNA Cells,Disease Recurrence Monitoring,Measurable Residual Disease,Molecular Genetic Testing,Molecular Residual Disease,Personalized Monitoring,Prognosis,Serial Monitoring,Solid Tumor,Therapeutic Targets,Treatment Response Assessment,Tumor-Guided MRD Testing,Tumor-Informed Disease Surveillance,Tumor-Informed Monitoring,ctDNA,CFDNA,Next Generation Sequencing,Liquid Biopsy,CT-DNA,CTCS,Cell Free DNA
Specimen requirements | |
|---|---|
| Patient preparation | None Specified |
| Preferred specimen(s) | 30 mL whole blood collected in 3 Streck cell-free (black/tan tiger-top) glass tubes |
| Minimum volume | 24 mL |
| Collection instructions | Sample collection using a straight needle is preferred. Use Streck tubes only. All tubes must be filled completely. Gently invert tube at least 8 times immediately after draw. Please note: If Hospital Discharge Date is not populated, outpatient treatment is assumed. |
| Transport container | Cell-free DNA Streck tube(s) |
| Transport temperature | Room temperature |
| Specimen stability | Room temperature: 7 days Refrigerated: Unacceptable Frozen: Unacceptable |
| Reject criteria | Hemolysis |
Reference ranges are provided as general guidance only. To interpret test results use the reference range in the laboratory report.
*The CPT codes provided are based on AMA guidance and are for informational purposes only. CPT coding is the sole responsibility of the billing party. Please direct any questions regarding coding to the payer being billed.
This material contains content from LOINC® (http://loinc.org). The LOINC Table, LOINC Table Core are copyright © 1995-2019, Regenstrief Institute, Inc. and the Logical Observation Identifiers Names and Codes (LOINC) Committee and is available at no cost under the license at http://loinc.org/license.
The tests listed by specialty and category are a select group of tests offered. For a complete list of Quest Diagnostics tests, please adjust the filter options chosen, or refer to our Directory of Services.